Workflow
Barclays Maintains Buy on Solaris (SEI) With $44 Price Target
Yahoo Finance· 2025-09-11 07:31
Solaris Energy Infrastructure Inc. (NYSE:SEI) is one of the best multibagger stocks to invest in right now. On September 3, Barclays analyst David Anderson reiterated a Buy rating on Solaris Energy Infrastructure (NYSE:SEI) with an unchanged $44 price target. This stance by the analyst follows his July 28 decision to lift the target from $39 after the company delivered strong Q2 results and raised Q3 EBITDA guidance. Barclays Maintains Buy on Solaris (SEI) With $44 Price Target Anderson described the qu ...
TD Cowen Reaffirms Buy on Strategy (MSTR), Trims Target to $640
Yahoo Finance· 2025-09-11 07:31
Strategy Inc. (NASDAQ:MSTR) is one of the best multibagger stocks to invest in right now. The company positions itself as the world’s largest Bitcoin Treasury Company, a strategy shaped by CEO Michael Saylor’s view that bitcoin will replace gold as a non-governmental store of value. As of the end of July, the company held 628,791 bitcoins on its balance sheet, valued at about $70 billion at current prices. TD Cowen Reaffirms Buy on Strategy (MSTR), Trims Target to $640 Photo by Jievani Weerasinghe on Uns ...
Precigen’s (PGEN) Papzimeos Push Sparks Multibagger Ascent, Boosted by Analyst Optimism
Yahoo Finance· 2025-09-11 07:31
Precigen Inc. (NASDAQ:PGEN) is one of the best multibagger stocks to invest in right now. Among the company’s proprietary therapeutic platforms, its UltraCAR-T platform offers a differentiated approach to CAR-T treatment, aiming for faster manufacturing and potentially improved safety profiles. The company has multiple candidates progressing through clinical trials, which are being used to build a robust pipeline that addresses significant unmet medical needs. Precigen’s (PGEN) Papzimeos Push Sparks Multi ...
Aeva Technologies’ (AEVA) Multibagger Momentum Fueled by LiDAR Innovation in $80 Billion Market
Insider Monkey· 2025-09-11 07:31
Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal! AI is eating the world—and the machines behind it are ravenous. Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy. In fact, AI is already pushing global power grids to the brink. Wall Street is pouring hundreds of billions into artificial intelligence—training smarter chatbots, automating industries, and b ...
Corcept’s (CORT) Multibagger Momentum Builds on Relacorilant and Expanding Commercial Footprint
Yahoo Finance· 2025-09-11 07:31
Corcept Therapeutics Inc. (NASDAQ:CORT) is one of the best multibagger stocks to invest in right now. The company has recently revised its 2025 revenue guidance to $850-$900 million, down from the previous range of $900-$950 million. Despite the adjustment, management reiterated confidence in the company’s growth trajectory, pointing to contributions from an expanded sales force, new pharmacy partnerships, and progress in its pipeline. Corcept's (CORT) Multibagger Momentum Builds on Relacorilant and Expan ...
Microvast (MVST) is Scaling Production to Capture Energy Storage Growth
Yahoo Finance· 2025-09-11 07:31
Microvast Holdings Inc. (NASDAQ:MVST) is one of the best multibagger stocks to invest in right now. The company is positioned to benefit from the global shift toward electrification, supported by rising EV adoption and favorable government policies. Microvast Holdings Inc. (NASDAQ:MVST) develops and manufactures advanced lithium-ion battery solutions tailored for electric vehicles and energy storage, two of the fastest-growing markets in the energy transition. Microvast (MVST) is Scaling Production to Cap ...
Haduvio Opportunity Positions Trevi (TRVI) for Multibagger Gains, Says Morgan Stanley
Yahoo Finance· 2025-09-11 07:31
Trevi Therapeutics Inc. (NASDAQ:TRVI) is one of the best multibagger stocks to invest in right now. On August 21, Morgan Stanley’s Judah Frommer initiated coverage of the stock with an Overweight rating and an $18 price target. The Overweight call is based on Haduvio, the company’s extended-release formulation of nalbuphine, which is being developed as a treatment for chronic cough. Haduvio Opportunity Positions Trevi (TRVI) for Multibagger Gains, Says Morgan Stanley Frommer said Haduvio stands out in a ...
Guggenheim Sees Compass (CMPX) Potential Driven by Biliary Tract Cancer Pipeline
Yahoo Finance· 2025-09-11 07:31
Compass Therapeutics Inc. (NASDAQ:CMPX) is one of the best multibagger stocks to invest in right now. The company’s lead program, CTX-009, is progressing through clinical trials for advanced solid tumors, particularly biliary tract cancer (BTC), where the company estimates a market opportunity exceeding $1 billion. Notably, Compass Therapeutics Inc. (NASDAQ:CMPX) is pointing out a significant unmet medical need, as around 85% of BTC patients who fail first-line therapy have no approved, effective treatment ...
Piper Sandler Reiterates Buy as Seralutinib Momentum Boosts Gossamer (GOSS) Multibagger Case
Yahoo Finance· 2025-09-11 07:31
Gossamer Bio Inc. (NASDAQ:GOSS) is one of the best multibagger stocks to invest in right now. The company’s focus lies on its lead asset, Seralutinib, which targets pulmonary arterial hypertension (PAH), a severe condition with limited treatment options. Investor enthusiasm for the stock has grown markedly this year. It was trading around $1 at the start of the year and has since climbed to $2.50, delivering nearly 180% returns year-to-date. Piper Sandler Reiterates Buy as Seralutinib Momentum Boosts Goss ...
Lead Therapy Trial Fuels aTyr Pharma’s (ATYR) Promising Upside, Leerink Stays Bullish
Yahoo Finance· 2025-09-11 07:31
aTyr Pharma Inc. (NASDAQ:ATYR) is one of the best multibagger stocks to invest in right now. On August 22, Leerink Partners’ Faisal Khurshid reiterated a Buy rating on aTyr Pharma Inc. (NASDAQ:ATYR) with a $16 price target. His view reflects optimism around the EFZO-FIT trial, which is testing efzofitimod as a potential treatment for pulmonary sarcoidosis. Lead Therapy Trial Fuels aTyr Pharma (ATYR) Promising Upside, Leerink Stays Bullish Tonhom1009/Shutterstock.com Khurshid highlights that feedback fro ...